Medical researchers have reported a major breakthrough in the development of a new cancer vaccine that has shown encouraging results in patients with advanced and recurring cancers. The vaccine, known as Amivantamab, is currently being tested in clinical trials across 11 countries. Researchers say early results have been highly promising, with some patients experiencing complete The post New cancer vaccine eliminates tumors in clinical trial appeared first on MM News.



